openPR Logo
Press release

Ocular Pain Treatment Market 2023 - Key Players Analysis SYLENTIS, Bristol-Myers Squibb, SUN PHARMA, Reata Pharmaceuticals, Inc., Ocular Therapeutix, Inc.

12-05-2018 08:40 PM CET | Health & Medicine

Press release from: Prescient & Strategic Intelligence

Ocular Pain Treatment Market 2023 - Key Players Analysis

The global ocular pain treatment market is expected to witness considerable growth due to increasing awareness about the eye disorders, technological advancement in ocular therapeutic and diagnostic test, and increasing number of lifestyle related ocular diseases. In addition, increasing geriatric population and increasing disposable income are further supporting the growth of the global ocular pain market.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/ocular-pain-treatment-market/report-sample

The pharmaceutical companies are actively involved in the research and development of drugs for ocular pain. Loteprednol etabonate, a Mucus-Penetrating Particle platform technology based Phase III clinical trial drug of Kala Pharmaceuticals, Inc., is nanotechnology based products for the treatment of ocular pain.

A large number of pharmaceutical companies are constantly working for the research and development of ocular pain treatment. However, certain factors such as high treatment cost, less awareness about the eye disease among population and lack of favorable government policy are the key factors hindering the growth of the global market during the forecast period.

Browse report at: https://www.psmarketresearch.com/market-analysis/ocular-pain-treatment-market

Geographically, North America is expected to be the largest market for ocular pain treatment owing to the favorable healthcare infrastructure and government initiatives, increasing number of research and development activities, and high awareness about the eye disease and its precautions. The U.S. contributed largest revenue to the North American ocular pain market and it is expected to remain the largest market globally, during the forecast period.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=ocular-pain-treatment-market

Some of the key players operating in the global ocular pain market are ICON Bioscience Inc., Xigen S.A., Sylentis S.A., Bayer AG, Bristol Meyer Squibb Company, Merck and Co., Inc., Sun Pharmaceutical Industries Ltd., Reata Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc. and Ocular Therapeutix, Inc.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ocular Pain Treatment Market 2023 - Key Players Analysis SYLENTIS, Bristol-Myers Squibb, SUN PHARMA, Reata Pharmaceuticals, Inc., Ocular Therapeutix, Inc. here

News-ID: 1420266 • Views:

More Releases from Prescient & Strategic Intelligence

Global Automation Market Set to Reach $161.6 Billion by 2030: AI and IoT Drive I …
According to the latest market research study published by P&S Intelligence, the global automation market will generate an estimated revenue of USD 129.5 billion in 2024, which is expected to witness a CAGR of 3.8% during 2024-2030, to reach USD 161.6 billion by 2030. The most significant driving force behind the growth of the market is the technological development occurring in the world and the need for improvement of different
Market Trends in Marine Onboard Communication and Control Systems
Market Trends in Marine Onboard Communication and Control Systems
In 2023, the global market for marine onboard communication and control systems reached USD 8,733.2 million, projected to grow to USD 14,496.2 million by 2030, with a compound annual growth rate (CAGR) of 7.7%. This growth is driven by several factors including increased emphasis on fleet modernization, expanding global trade, and advancements in control solutions and marine communication technologies. There is also a growing demand for higher automation and connectivity in
Biobanking Services Market by Biobank Type, Service Type, Ownership, Application and Geography Forecast to 2024 - P&S Intelligence
Biobanking Services Market by Biobank Type, Service Type, Ownership, Application …
The global biobanking services market is expected to broaden during the forecast period, mainly on account of growing prevalence of chronic diseases, use of blood biomarkers in early detection of various types of cancersincreasing genomic research activities for studying diseases, growing trend of conserving cord blood stem cells of newborns, surging government and private funding to support regenerative medicine research, and growing need for cost-effective drug discovery and development. Download free
Patient Engagement Solutions Market 2013-2023 by Key Companies are - athenahealth, Cerner Corporation, IBM, eClinicalWorks, InterSystems, Epic
Patient Engagement Solutions Market 2013-2023 by Key Companies are - athenahealt …
The patient engagement solutions market for software is expected to reach $12.3 billion by 2023, registering a CAGR of 16.6% during the forecast period. Patient engagement software is increasingly being adopted by healthcare facilities, as it helps simplify complex patient health data and can also be customized according to requirements. Download free report sample at: https://www.psmarketresearch.com/market-analysis/patient-engagement-solutions-market/report-sample During the forecast period, the patient engagement solutions market is expected to witness the highest demand

All 5 Releases


More Releases for P&S

Only 17 Stocks in the S&P 500 Have Outperformed the S&P 500 Index in EACH of the …
Image: https://www.getnews.info/wp-content/uploads/2024/04/1711974100.png Washington, DC - April 1, 2024 - 17 stocks in the S&P 500 have consistently beaten the performance of the S&P 500 index on an annual basis over each of the last 4 years. At StoxxUSA.org, our equity analysis team has identified these StoxxUSA "Stars" which have beaten their respective index in each of the last 4 years. Image: https://www.getnews.info/uploads/e8f37ff33afc4fe8e335ecca5313f8f4.jpg The S&P "Stars" Report is prepared by StoxxUSA.org. StoxxUSA.org is not
Europe is Dominating Glycolic Acid Industry - P&S Intelligence
The glycolic acid market was valued at USD 309.3 million in 2021, and it is set to reach USD 604.4 million by 2030, growing at a CAGR of 7.7% between 2021 and 2030, according to a research report by a market research company P&S Intelligence. In 2021, the personal care and cosmetics category held the largest market share at 58.2%. this is due to glycolic acid being extensively utilized in skincare
Immunotherapy Drugs Market Opportunity Assessment Study - P&S Intelligence
Hospitals and clinics were the key end users in the immunotherapy drugs market, with 81.0% contribution in 2017. The adoption of immunotherapy drugs has been increasing in hospitals and clinics, owing to growing patient population, increasing healthcare expenditure, and rising prevalence of chronic diseases, leading to dominate the end-user segment. North America was the largest immunotherapy drugs market during the historical period, with more than 50.0% contribution in 2017. This can
Neurostimulation Device Market Opportunity Assessment Study - P&S Intelligence
The neurostimulation device market is growing, due to increasing geriatric population, increasing prevalence of chronic pain, and increasing incidents of neurological disorders. In addition, the awareness about mental diseases and their treatment is also increasing across the globe. Explore Report with Detailed TOC on “Global Neurostimulation Device Market” at: https://www.psmarketresearch.com/market-analysis/neurostimulation-devices-market The information and data in the publication “Global Neurostimulation Device Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the
P&S Market Research
Isobutanol is expected to perceive significant demand as an alternative to conventional fuel. The high demand of the product is attributed to its increasing adoption as an alternative for ethanol in gasoline. It is widely used in the production of isobutyl acetate. The isobutanol market is driven by wide acceptance in the various consumer product industries, such as food processing industry and lacquer. Get Sample Copy of This Report @https://www.psmarketresearch.com/market-analysis/isobutanol-market/report-sample On the
P&S Market Research
Supercapacitor Market Size, Share, Development, Growth and Demand Forecast to 2020 The growing need for increased battery life in smartphone, laptop, and other similar consumer electronics products has increased the market penetration of supercapacitors in various new applications. Supercapacitors are now used for the extended battery backup in smartphone, and laptops; moreover, the replacement of conventional capacitor with them is expected to drive the growth of the global market during the